Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Boston Scientific recalls premixed embolic agent after two deaths
There have been a total of 11 incidents so far, including seven injuries and two deaths. Boston Scientific said the agent can still be used if operators follow specific instructions during lower GI bleed embolization procedures.
Anemia may help explain why women are more likely to die during heart bypass surgery
Finding new ways to avoid intraoperative anemia could go a long way toward improving outcomes for female CABG patients. The full analysis, based on more than 1.4 million patients, was published in the Journal of the American College of Cardiology.
FDA grants anticoagulant its orphan drug designation for treating patients with implanted devices
The anticoagulant was originally developed for patients with end-stage renal disease and atrial fibrillation.
FDA announces new recall of neurovascular catheters built by Johnson & Johnson subsidiary
The recall is due to ongoing concerns about the devices breaking. Three patients have been injured as a result of this issue.
GE Healthcare launching new AI software for handheld ultrasound system
The company's new AI offering, a product of its 2023 acquisition of Caption Health, will make its debut at ACC.24 in Atlanta.

Vienna Aortic Self-Expandable Transcatheter Valve premounted on the delivery system

New TAVR valve, premounted to save cardiologists time, linked to promising 30-day outcomes

The new valve arrives fully premounted on a delivery system and was designed to allow resheathing or complete recapture/redeployment if necessary.

August 16, 2023

doctor with overweight patient who may be treated with TAVR or surgery

Weight loss drug semaglutide could boost heart health of up to 93M patients in US alone

Researchers have recently determined that the medication, originally developed to treat diabetes, can contribute to weight loss and reduce a patient's MACE risk by up to 20%.

August 15, 2023

Alternative access approaches for transcatheter aortic valve replacement (TAVR) procedures. courtesy of Interventional Cardiology Review 2018;13(3):145–50.

Alternative TAVR techniques: How to proceed when transfemoral access is not recommended

A team of researchers from the United States and Sweden explored data from nearly 12,000 TAVR patients for a new systematic review and meta-analysis.

August 11, 2023

Expanding Medicaid linked to better care for heart patients

New research, based on data from approximately 143 million patients, focused on prescriptions for heart failure, atrial fibrillation and other significant cardiac conditions.

August 3, 2023

Medicare money payment physician. The CardioVascular Coalition and Society for Cardiovascular Angiography and Interventions have both issued new statements highlighting their issues with the 2024 MPFS proposed rule.

More cardiology groups step forward with concerns about Medicare payment cuts

The CardioVascular Coalition and Society for Cardiovascular Angiography and Interventions have both issued new statements highlighting their issues with the 2024 MPFS proposed rule.

July 26, 2023

a patient talks with her doctor, both are women of color

Heart specialists receive nearly $30M to study PCI and CABG among underrepresented patient groups

Teams from the Icahn School of Medicine at Mount Sinai and Weill Cornell Medicine will collaborate on the research.

July 25, 2023

Medtronic has received FDA approval for its IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter. FDA clears new drug eluting balloon, drug-coated balloon.

FDA says treating PAD with paclitaxel-coated devices does not increase mortality risk

After warning healthcare providers about a heightened risk of mortality back in 2019, the FDA has now updated its stance on the use of these devices.

July 11, 2023

IVUS guidance during DES implantation boosts long-term outcomes in new study

Heart failure symptoms after PCI increase risk of adverse events

Researchers in Japan tracked BNP levels and bleeding events among more than 7,000 PCI patients. The group noted that managing heart failure in the first 30 days after PCI can help boost outcomes.

July 7, 2023

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Vascular & Endovascular

Boston Scientific recalls premixed embolic agent after two deaths

Anemia may help explain why women are more likely to die during heart bypass surgery

FDA grants anticoagulant its orphan drug designation for treating patients with implanted devices

FDA announces new recall of neurovascular catheters built by Johnson & Johnson subsidiary

GE Healthcare launching new AI software for handheld ultrasound system

Around the web